ICCM — IceCure Medical Ltd.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1584371 ·
Israel
Last close
$2.27
Market Cap
$7.78M
52W High
$9.54
52W Low
$2.12
ADV30
133,690
Next earnings
2026-08-12
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 911,000 | 295,000 | -4,247,000 | -4,274,000 | 13,303,000 | 8,115,000 | 4,809,000 |
| Dec 2025 | 1,279,000 | 600,000 | -4,216,000 | -4,246,000 | 13,888,000 | 8,897,000 | 4,837,000 |
| Sep 2025 | 850,000 | 277,000 | -3,836,000 | -3,859,000 | 15,078,000 | 4,971,000 | 5,772,000 |
| Jun 2025 | 525,000 | 131,000 | -3,385,000 | -3,364,000 | 10,589,000 | 5,383,000 | 7,698,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-14,806,000
Investing CF
$-82,000
Financing CF
$16,809,000
CapEx
$-81,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.60
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-124,710,000
Inventory
$2,646,000
Receivables
$1,363,000
ST Investments
$5,034,000
EBIT TTM
$-15,684,000
Pretax Income TTM
$-15,743,000
Interest Exp TTM
—
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$3,947,000
EBITDA
$-16,439,000
Free Cash Flow
$-9,538,000
Enterprise Value
$-3,617,082
Total Cash
$12,034,000
Total Debt
$90,000
Shares Out
3,426,715
Trailing EPS
$-6.78
Book Value
$3.47
ROE
-228.3%
ROA
-73.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 3,379,000 | -15,094,000 | -15,057,000 | 13,888,000 | 4,837,000 | — | -14,574,000 |
| Dec 2024 | 3,291,000 | -15,696,000 | -15,318,000 | 12,576,000 | 5,675,000 | — | -12,563,000 |
| Dec 2023 | 3,229,000 | -15,576,000 | -14,652,000 | 16,410,000 | 4,247,000 | — | -12,550,000 |
| Dec 2022 | 3,085,000 | -16,739,000 | -16,978,000 | 30,188,000 | 4,766,000 | — | -14,292,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-3.31
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CODX | Co-Diagnostics, Inc. | $7.63M | $1.22 | — |
| INBS | INTELLIGENT BIO SOLUTIONS INC. | $7.55M | $2.50 | — |
| NVNO | enVVeno Medical Corp | $7.07M | $10.35 | — |
| NXL | Nexalin Technology, Inc. | $6.95M | $0.32 | — |
| OSRH | OSR Health, Inc. | $8.78M | $0.25 | — |
News headlines (Yahoo Finance, 1h cache)
IceCure Signs Exclusive Distribution Agreement for ProSense® Cryoablation Systems in the Netherlands
2026-08-24 11:50 · Yahoo
Icecure Medical Ltd (ICCM) (Q2 2026) Earnings Call Highlights: Revenue Surges 45% as US ...
2026-08-20 03:01 · Yahoo
IceCure Medical (ICCM) Q2 2026 Earnings Call Transcript
2026-08-19 15:43 · Yahoo
IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation
2026-08-13 13:10 · Yahoo
IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year
2026-08-12 12:30 · Yahoo
IceCure Medical to Report First Half 2026 Financial and Operating Results on August 12, 2026
2026-08-05 12:30 · Yahoo
IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site
2026-07-27 12:32 · Yahoo
IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation
2026-07-14 12:32 · Yahoo
IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer
2026-07-06 12:11 · Yahoo
IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional Investor
2026-06-17 17:14 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.